Company intelligence / Profile preview

XYMOGEN

Orlando, Florida, United States

Ownership: Private
Employees: ~430
Development stage: Other

Overview

XYMOGEN develops and manufactures over 300–400 science-backed dietary supplement products for diverse functional and integrative health needs, distributed primarily through licensed healthcare practitioners. No clinical drug trial results as products are dietary supplements, not drugs[2][4][8].

Therapeutic areas: ImmunologyEndocrinologyMen's HealthCardiovascularOtherNeurologyWomen's Health
Modalities: Small moleculeProteinProbioticPeptidesBotanical extractVitaminsMineralsFunctional food
Industry: Food & Nutrition

Partnerships

Clorox (Renew Life)Isagenix

Beyond the preview

Go deeper on XYMOGEN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XYMOGEN.

Explore the full profile